© 2020 MJH Life Sciences and OncLive. All rights reserved.
August 03, 2020
Ruben A. Mesa, MD, discusses the potential utility of CAR T-cell therapy in myeloproliferative neoplasms.
July 23, 2020
Ruben A. Mesa, MD, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms.
July 17, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses recent data with momelotinib in myelofibrosis.
April 16, 2020
Ruben A. Mesa, MD, discusses advancements made in the treatment of patients with myeloproliferative neoplasms.